The 6 Peptide Research Categories: Recovery, Metabolic, Cognitive, Anti-Aging, Immune, Hormonal

Research peptides span a broad range of biological mechanisms, but the scientific literature and commercial landscape have organized them into six primary categories based on their predominant area of investigation. These categories — recovery, metabolic, cognitive, anti-aging, immune, and hormonal — provide a useful framework for understanding the peptide research landscape, the types of studies being conducted, and the relative maturity of evidence for each class.

Each category contains peptides at different stages of research, from early preclinical studies in cell cultures and animal models to advanced clinical trials in humans. Understanding where a specific peptide falls on this evidence spectrum is critical for evaluating vendor claims and designing rigorous experiments [1].

Recovery peptides are the most widely studied category in peptide research. These compounds are investigated for their roles in tissue repair, wound healing, and regenerative processes. The recovery category has some of the strongest preclinical evidence, with multiple peptides advancing into clinical trials [2][3].

• BPC-157 (Body Protection Compound): A 15-amino acid peptide derived from gastric juice proteins. Investigated for tendon, ligament, muscle, and gastrointestinal tissue repair. Over 100 published animal studies demonstrate accelerated healing in various injury models. MW: 1419.53 [2]
• TB-500 (Thymosin Beta-4 fragment): A 43-amino acid peptide involved in actin regulation and cell migration. Research focuses on wound healing, cardiac tissue repair, and anti-inflammatory effects. Multiple Phase II clinical trials completed. MW: 4963.50 [3]
• GHK-Cu (Copper peptide): A tripeptide-copper complex naturally present in human plasma. Studied for skin wound healing, collagen synthesis stimulation, and anti-inflammatory signaling. MW: 403.93 [4]
• KPV (Lys-Pro-Val): A tripeptide derived from alpha-MSH. Investigated for anti-inflammatory properties in intestinal and skin tissue models
• Pentadecapeptide BPC-157 variants: Modified sequences under investigation for enhanced stability and targeted tissue delivery

Metabolic peptides are studied for their effects on energy metabolism, fat oxidation, glucose regulation, and body composition. This category has grown significantly due to the broader research interest in metabolic syndrome and obesity-related pathways [5].

• AOD-9604: A modified fragment (amino acids 177-191) of human growth hormone. Investigated specifically for lipolytic (fat-reducing) activity without the broader effects of full-length GH. Completed Phase IIb clinical trials for obesity. MW: 1815.08 [5]
• MOTS-c (Mitochondrial ORF of the 12S rRNA type-c): A mitochondria-derived peptide of 16 amino acids. Research focuses on exercise mimetic effects, insulin sensitivity, and metabolic homeostasis. MW: 2174.70 [6]
• 5-Amino-1MQ: A small molecule inhibitor of NNMT (nicotinamide N-methyltransferase). Studied in obesity models for its effects on fat cell metabolism and energy expenditure
• Tesamorelin: A growth hormone-releasing hormone analog approved for HIV-associated lipodystrophy. Investigated for broader metabolic applications. MW: 5135.90
• Fragment 176-191: The unmodified C-terminal fragment of human growth hormone. Studied alongside AOD-9604 as a reference compound in lipolysis research

Cognitive peptides are investigated for effects on memory formation, neuroprotection, anxiety modulation, and overall cognitive performance. This category intersects with neuroscience and pharmacology, and several compounds have been studied in human clinical settings [7][8].

• Selank: A synthetic analog of the immunomodulatory peptide tuftsin, with an additional Gly-Pro sequence. Investigated for anxiolytic and nootropic effects. Approved in Russia as an anxiolytic pharmaceutical. MW: 863.97 [7]
• Semax: An analog of ACTH(4-7) with a Pro-Gly-Pro C-terminal extension. Studied for neuroprotective and cognitive-enhancing effects. Also approved in Russia for clinical use. MW: 813.93 [8]
• Dihexa: A hexapeptide derived from angiotensin IV. Investigated for its potent effects on hepatocyte growth factor signaling and synaptic connectivity in animal models
• PE-22-28 (Spadin analog): A peptide derived from the propeptide of sortilin. Research focuses on TREK-1 potassium channel modulation and antidepressant-like effects in animal models
• FGL (FG Loop peptide): A peptide derived from the neural cell adhesion molecule (NCAM). Studied for effects on synaptic plasticity and memory consolidation

Anti-aging peptides target cellular senescence, telomere biology, collagen production, and oxidative damage. While the category name is popular in commercial contexts, the underlying research addresses fundamental cellular mechanisms of aging [4][9].

• Epithalon (Epitalon): A tetrapeptide (Ala-Glu-Asp-Gly) studied for its effects on telomerase activation. Research by Professor Vladimir Khavinson demonstrated telomere elongation in cell culture models. MW: 390.35 [9]
• GHK-Cu: Also listed under recovery — research on GHK-Cu spans both wound healing and anti-aging due to its effects on collagen synthesis, antioxidant gene expression, and DNA repair signaling [4]
• FOXO4-DRI: A modified peptide that disrupts the FOXO4-p53 interaction in senescent cells. Investigated for selective clearance of senescent cells (senolytic activity) in mouse models
• Thymalin: A peptide complex extracted from calf thymus. Studied by Khavinson and colleagues for immunomodulatory effects in aging populations
• SS-31 (Elamipretide): A mitochondria-targeted tetrapeptide. Clinical trials for mitochondrial dysfunction and age-related conditions including heart failure and Barth syndrome

Immune peptides modulate innate and adaptive immune responses. This category contains some of the most clinically advanced peptides, with several compounds in Phase III trials or approved for specific medical indications [10][11].

• Thymosin Alpha-1 (Ta1): A 28-amino acid peptide naturally produced by the thymus gland. Approved in over 35 countries for hepatitis B and C treatment. Extensive clinical trial data for immunomodulation in infection, cancer adjuvant therapy, and vaccine enhancement. MW: 3108.30 [10]
• LL-37: The only human cathelicidin antimicrobial peptide. A 37-amino acid peptide with broad-spectrum antimicrobial, anti-biofilm, and immunomodulatory properties. Active clinical research for wound infections and inflammatory conditions. MW: 4493.33 [11]
• Thymulin: A nonapeptide hormone produced by thymic epithelial cells. Requires zinc for biological activity. Studied for T-cell maturation and immune homeostasis
• BPC-157: Also appears in immune research due to demonstrated anti-inflammatory and cytoprotective properties in gastrointestinal inflammation models
• KPV: A tripeptide with potent anti-inflammatory activity. Studied in models of inflammatory bowel disease and dermatitis

Hormonal peptides interact with the endocrine system, primarily through the growth hormone (GH) axis, gonadotropin-releasing hormone (GnRH) pathways, or other hormonal signaling cascades. This is the most commercially active category and has the most extensive clinical trial data [12][13].

• CJC-1295: A modified growth hormone-releasing hormone (GHRH) analog with a Drug Affinity Complex (DAC) for extended half-life. Studied for sustained GH elevation. MW: 3367.97 [12]
• Ipamorelin: A selective growth hormone secretagogue receptor (GHS-R) agonist. Distinguished from other GH secretagogues by its selectivity — it stimulates GH release without significantly affecting cortisol or prolactin. MW: 711.85 [13]
• GHRP-6 (Growth Hormone Releasing Peptide-6): A hexapeptide GHS-R agonist. One of the earliest studied GH secretagogues. Also stimulates appetite through ghrelin receptor activation. MW: 873.01
• GHRP-2: A more potent GHS-R agonist than GHRP-6 with less appetite stimulation. Studied for GH deficiency and catabolic conditions. MW: 817.97
• Gonadorelin: Synthetic GnRH (gonadotropin-releasing hormone). Used clinically for fertility diagnostics and treatment. MW: 1182.29
• PT-141 (Bremelanotide): A melanocortin receptor agonist derived from Melanotan II. FDA-approved (Vyleesi) for hypoactive sexual desire disorder. MW: 1025.18

The depth of clinical evidence varies significantly across the six categories. Researchers should consider the evidence tier when evaluating peptides for experimental protocols:

• Tier 1 — FDA-approved or equivalent: Hormonal peptides (PT-141/Bremelanotide, Tesamorelin, Gonadorelin) and immune peptides (Thymosin Alpha-1 in 35+ countries) have the strongest regulatory evidence
• Tier 2 — Phase II/III clinical trials: AOD-9604 (metabolic), TB-500/Thymosin Beta-4 (recovery), SS-31/Elamipretide (anti-aging), and Semax/Selank (cognitive, approved in Russia)
• Tier 3 — Extensive preclinical data: BPC-157 (recovery, 100+ animal studies), GHK-Cu (anti-aging/recovery), MOTS-c (metabolic), LL-37 (immune)
• Tier 4 — Early-stage research: FOXO4-DRI, Dihexa, PE-22-28, 5-Amino-1MQ — promising preclinical results but limited or no human clinical data

Selecting the appropriate peptide category for a research project depends on the biological question being investigated. Key considerations include:

• Define the primary biological endpoint: tissue repair, metabolic output, cognitive measure, biomarker of aging, immune parameter, or hormonal level
• Review the evidence tier for candidate peptides — prioritize compounds with published protocols in peer-reviewed journals
• Consider cross-category effects: many peptides have pleiotropic actions that may confound results if not controlled for
• Evaluate practical factors: peptide stability, required storage conditions, reconstitution protocols, and analytical verification methods
• Verify vendor quality: use third-party COA verification and HPLC purity data before incorporating any peptide into experimental work

No. Many peptides have research applications across multiple categories. BPC-157 appears in recovery, immune, and metabolic research. GHK-Cu spans recovery and anti-aging. The primary category reflects the most extensively studied mechanism.

Recovery and hormonal peptides have the most published protocols and standardized experimental methods, making them accessible for researchers new to peptide work. The extensive literature base provides clear guidance on concentrations, controls, and expected outcomes.

No. Different sources may use alternative classification schemes. Some group peptides by structural features (cyclic, linear, stapled) or by receptor target. The six-category system used here reflects the most common functional grouping in the research peptide community and commercial literature.

Explore detailed chemical profiles and research guides for compounds discussed in this article:

• BPC-157: Complete Research Guide → /learn/bpc-157
• CJC-1295: Complete Research Guide → /learn/cjc-1295-no-dac
• GHK-Cu: Complete Research Guide → /learn/ghk-cu
• Selank: Complete Research Guide → /learn/selank
• TB-500: Complete Research Guide → /learn/tb-500
• Thymosin Alpha 1: Complete Research Guide → /learn/thymosin-alpha-1

• Read more: GHK-Cu for Skin Research: Copper Peptide Mechanism Explained → https://www.chemverify.com/learn/ghk-cu-skin-research-copper-peptide-mechanism
• Read more: Peptide Cycling: How Long to Research and When to Pause → https://www.chemverify.com/learn/peptide-cycling-research-duration-pause
• Read more: How TB-500 Works Biochemically: Thymosin Beta-4, Actin, and Tissue Repair → https://www.chemverify.com/learn/tb-500-mechanism-thymosin-beta-4-tissue-repair
• Read more: Pentadeca Arginate (PDA): Research Guide & Chemical Profile → https://www.chemverify.com/learn/pentadeca-arginate-pda-research-guide